secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arch Therapeutics, Inc. (—)
CIK:        0001537561
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001493152-24-034600
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Laurence Hicks resigns from Arch Therapeutics board effective August 28, 2024
--------------------------------------------------------------------------------

- Laurence Hicks resigned as Board member on August 28, 2024, effective immediately.
- No disagreements of any kind exist between Mr. Hicks and the company regarding his resignation.
- The filing does not announce a replacement for the departing director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1537561/000149315224034600/0001493152-24-034600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1537561/000149315224034600/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-034600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer